Abstract
Background: Elevated plasma homocysteine has been found to be associated with an increased risk of osteoporosis, especially hip and vertebral fractures. The plasma concentration of homocysteine is dependent on the activities of several B vitamin-dependent enzymes, such as methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and cystathionine β-synthase (CBS). Objectives: We investigated whether genetic variants in some of the genes involved in 1 carbon metabolism modify the association of B vitamin-related measures with bone mineral density (BMD) and strength. Methods: We measured several B vitamins and biomarkers in participants of the Framingham Offspring Study, and performed analyses of methylmalonic acid (MMA) continuously and <210 nmol/L; pyridoxal-5'-phosphate; vitamin B-12 continuously and ≥258 pmol/L; and folate. The outcomes of interest included areal and volumetric BMD, measured by DXA and quantitative computed tomography (QCT), respectively. We evaluated associations between the bone measures and interactions of single nucleotide polymorphism with a B vitamin or biomarker in Framingham participants (n = 4310 for DXA and n = 3127 for QCT). For analysis of DXA, we validated the association results in the B-PROOF cohort (n = 1072). Bonferroni-corrected locus-wide significant thresholds were defined to account for multiple testing. Results: The interactions between rs2274976 and vitamin B-12 and rs34671784 and MMA <210 nmol/L were associated with lumbar spine BMD, and the interaction between rs6586281 and vitamin B-12 ≥258 pmol/L was associated with femoral neck BMD. For QCT-derived traits, 62 interactions between genetic variants and B vitamins and biomarkers were identified. Conclusions: Some genetic variants in the 1-carbon methylation pathway modify the association of B vitamin and biomarker concentrations with bone density and strength. These interactions require further replication and functional validation for a mechanistic understanding of the role of the 1-carbon metabolism pathway on BMD and risks of fracture.
Original language | English |
---|---|
Pages (from-to) | 578-587 |
Number of pages | 10 |
Journal | American Journal of Clinical Nutrition |
Volume | 114 |
Issue number | 2 |
DOIs | |
State | Published - 2 Aug 2021 |
Bibliographical note
Publisher Copyright:© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
Funding
This work was partially supported by the National Heart, Lung and Blood Institute’s FHS (contract numbers N01-HC-25195 and HHSN268201500001I) and its contract with Affymetrix, Inc. for genotyping services (contract number N02-HL-6-4278). This work was also supported in part by a grant from the National Institutes of Arthritis Musculoskeletal and Skin Diseases (R01 AR041398), a grant from Samson Family Foundation, and by the USDA Agricultural Research Service (agreement number #58-1950-4-003). The B Vitamins for the Prevention of Osteoporotic Fractures study (B-PROOF) is supported and funded by The Netherlands Organization for Health Research and Development (ZonMw; grant 6130.0031), the Hague; an unrestricted grant from NZO (Dutch Dairy Association), Zoetermeer; Orthica, Almere; NCHA (Netherlands Consortium Healthy Ageing) Leiden/Rotterdam; Ministry of Economic Affairs, Agriculture and Innovation (project KB-15-004-003), the Hague; Wageningen University, Wageningen; Vrije University medical center, Amsterdam; Erasmus Medical Center, Rotterdam; and Unilever, Colworth, UK. All organizations, except Unilever, are based in the Netherlands.
Funders | Funder number |
---|---|
NCHA | |
Samson Family Foundation | |
National Heart, Lung, and Blood Institute | N02-HL-6-4278, N01-HC-25195, HHSN268201500001I |
National Institute of Arthritis and Musculoskeletal and Skin Diseases | R01AR041398 |
Unilever | |
Agricultural Research Service | 58-1950-4-003 |
ZonMw | 6130.0031 |
Nederlandse Zuivel Organisatie | |
Ministerie van Economische Zaken, Landbouw en Innovatie | KB-15-004-003 |
Keywords
- B vitamins
- DXA
- QCT
- bone mineral density
- genetic polymorphism